These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19004964)

  • 1. Age, comorbidity, treatment decision and prognosis in lung cancer.
    Blanco JA; Toste IS; Alvarez RF; Cuadrado GR; Gonzalvez AM; Martín IJ
    Age Ageing; 2008 Nov; 37(6):715-8. PubMed ID: 19004964
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac comorbidity is not a risk factor for mortality and morbidity following surgery for primary non-small cell lung cancer.
    Mishra PK; Pandey R; Shackcloth MJ; McShane J; Grayson AD; Carr MH; Page RD
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):439-43. PubMed ID: 19081729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of older patients with non-small-cell lung cancer: walking the therapeutic tightrope.
    Simon GR
    J Clin Oncol; 2010 Feb; 28(4):523-6. PubMed ID: 20038720
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.
    Lavolé A; Chouaïd C; Baudrin L; Wislez M; Raguin G; Pialoux G; Girard PM; Milleron B; Cadranel J
    Lung Cancer; 2009 Sep; 65(3):345-50. PubMed ID: 19135758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
    d'Amato TA; Ashrafi AS; Schuchert MJ; Alshehab DS; Seely AJ; Shamji FM; Maziak DE; Sundaresan SR; Ferson PF; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2009 Oct; 88(4):1079-85. PubMed ID: 19766784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
    Maione P; Rossi A; Di Maio M; Gridelli C
    Lung Cancer; 2009 Oct; 66(1):8-14. PubMed ID: 19328587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiochemotherapy in the elderly with lung cancer.
    Casas F; Kepka L; Agarwal JP; Dawotola D; Gaye P; Abdel-Wahab S; Vashkevitch L; Saghatelyan T; Perin B; Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1405-11. PubMed ID: 19827999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
    Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
    Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term results of lung resection for cancer in octogenarians.
    Voltolini L; Rapicetta C; Ligabue T; Luzzi L; Scala V; Gotti G
    Asian Cardiovasc Thorac Ann; 2009 Apr; 17(2):147-52. PubMed ID: 19592544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.
    Merritt RE; Mathisen DJ; Wain JC; Gaissert HA; Donahue D; Lanuti M; Allan JS; Morse CR; Wright CD
    Ann Thorac Surg; 2009 Nov; 88(5):1574-81; discussion 1581-2. PubMed ID: 19853115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age associated survival rate in non small cell lung cancer].
    Serrano-Olvera A; Gerson R
    Gac Med Mex; 2009; 145(1):27-35. PubMed ID: 19256408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
    Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting short- and long-term outcome.
    Veen EJ; Janssen-Heijnen ML; Ritchie ED; Biesma B; van den Bogart MP; Bolhuis RJ
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):260-4. PubMed ID: 19443491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
    Teramukai S; Kitano T; Kishida Y; Kawahara M; Kubota K; Komuta K; Minato K; Mio T; Fujita Y; Yonei T; Nakano K; Tsuboi M; Shibata K; Furuse K; Fukushima M
    Eur J Cancer; 2009 Jul; 45(11):1950-8. PubMed ID: 19231158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.